Barely Significant
← all excerpts

Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy.

Leuk Res Rep · 2013 · PMC3850368 · PMID 24371782

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
The three patients who started the IM intermittent treatment (cases 1, 5, and 6), showed a trend toward an improvement of leptin values. 4 Discussion We determined whether the long-term IM therapy induces leptin modification in young patients treated for CML.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.